New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
Mineralocorticoid receptor antagonists have been successfully used for many years to treat patients with primary hyperaldosteronism, refractory arterial hypertension and chronic heart failure. The increased interest in this drug in recent years is due to new information about its antifibrotic and an...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
"Consilium Medicum" Publishing house
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e182cb868ad24da2ad9e2ac5a9fda2c2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|